A Simple Score to Predict New-onset Atrial Fibrillation After Ablation of Typical Atrial Flutter

Zhoushan Gu, Jincheng Jiao, Xiangwei Ding, Chao Zhu, Mingfang Li, Hongwu Chen, Weizhu Ju, Kai Gu, Gang Yang, Hailei Liu, Pipin Kojodjojo, Minglong Chen
doi: https://doi.org/10.1101/2023.05.18.23290204

ABSTRACT

Background New-onset atrial fibrillation (NeAF) is common after cavotricuspid isthmus-dependent counterclockwise atrial flutter (CCW-AFL) ablation. This study aimed to investigate a simple predictive model of NeAF after CCW-AFL ablation.

Methods and Results From January 2013 to December 2017, consecutive patients receiving CCW-AFL ablation were enrolled from three centers. Clinical, echocardiographic, and electrocardiographic data were collected and followed. Patients from two centers and another center were assigned into the derivation and validation cohorts, respectively. In the derivation cohort, logistic regression was performed to evaluate the ability of parameters to discriminate those with and without NeAF. A score system was developed and then validated. Two hundred seventy-one patients (mean 59.7±13.6 age; 205 male) were analyzed. During follow-up (73.0±6.5 months), 107 patients (39.5%) had NeAF. 190 and 81 patients were detected in the derivation and validation cohorts, respectively. Hypertension, age ≥70 years, left atrial diameter ≥42 mm, P wave duration ≥120 ms and the negative component of flutter wave in lead II ≥120 ms were selected as the final parameters. A weighted score was used to develop the HAD-AF score ranging from 0 to 9. In the derivation cohort, area under the receiver operating characteristic curve (AUC) was 0.938 (95% CI 0.902-0.974), superior to those of currently used CHA2DS2-VASC (0.679, 95% CI 0.600-0.757) and HATCH scores (0.651, 95% CI 0.571-0.730) (P<0.001). Performance maintained in the validation cohort.

Conclusions 39.5% of patients developed NeAF in 6 years after CCW-AFL ablation. HAD-AF score can reliably identify patients likely to develop NeAF after CCW-AFL ablation.

What Is New?

  1. During a follow-up period of more than 6 years after CCW-AFL ablation, 107 of 271 (39.5%) patients developed NeAF.

  2. HAD-AF score, based on easily obtainable clinical, echocardiographic and electrocardiographic parameters, could better predict development of NeAF after CCW-AFL ablation (area under the receiver operating characteristics curve [AUC], 0.938), compared with currently used HATCH score (AUC, 0.651) and CHA2DS2-VASC score (AUC, 0.679) (P<0.001).

What Are the Clinical Implications?In CCW-AFL patients with a HAD-AF score >4, close postoperative follow-up for earlier detection of AF should be recommended, or the option of concomitant AF ablation could be considered during the shared decision-making process.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

None.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Ethics Committees of the First Affiliated Hospital of Nanjing Medical University, Affiliated Hospital of Nantong University, and Jiangsu Taizhou People's Hospital.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Conflict of interest statement: none.

Data Availability

All data referred to in the manuscript is available if needed.

  • Nonstandard Abbreviations and Acronyms

    AADs
    antiarrhythmic drugs
    AFNII
    amplitude of the negative component of flutter wave in lead II
    APNV1
    amplitude of negative component of the P wave in lead V1 under sinus rhythm
    CCW-AFL
    counterclockwise atrial flutter
    DFNII
    duration of the negative component of flutter wave in lead II
    DPII
    P wave duration in lead II under sinus rhythm
    DPNV1
    duration of negative component of the P wave in lead V1 under sinus rhythm
    LAD
    left atrial diameter
    LVEF
    left ventricular ejection fraction
    NeAF
    new-onset atrial fibrillation
    • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    Posted May 25, 2023.
    Download PDF
    Data/Code
    Email
    A Simple Score to Predict New-onset Atrial Fibrillation After Ablation of Typical Atrial Flutter
    Zhoushan Gu, Jincheng Jiao, Xiangwei Ding, Chao Zhu, Mingfang Li, Hongwu Chen, Weizhu Ju, Kai Gu, Gang Yang, Hailei Liu, Pipin Kojodjojo, Minglong Chen
    medRxiv 2023.05.18.23290204; doi: https://doi.org/10.1101/2023.05.18.23290204
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools

    Subject Area